Peru says China’s Sinopharm may resume coronavirus trial after volunteer’s illness

หน้าแรก / News / Peru says China’s Sinopharm may resume coronavirus trial after volunteer’s illness


https://www.straitstimes.com/world/peru-says-chinas-sinopharm-may-resume-coronavirus-vaccine-trial-after-volunteers-illness



            
                
                                            Recent News
เปิดโผ 4 กลุ่มแรก ได้ฉีดวัคซีนโควิด-19 ก่อน ฉีดคนละ 2 เข็ม ห่างกัน 1 เดือน
ทำไม “อินโดนีเซีย” ไม่ฉีดวัคซีนโควิดให้ผู้สูงอายุก่อน?
COVID-19 News: America Finally Has Its Own SARS-CoV-2 Variant COH.20G/501Y with More Worst and Complex Variants to Debut Shortly!
Vaccine News: 23 Deaths From Pfizer’s COVID-19 Vaccine in Norway, Chinese Urges Halt to mRNA Vaccines, Legal Suits for Those Saying Vaccines are Safe!
Vaccine News: Pfizer’s Study on Vaccine Effectiveness Against New Variants and Claims are Misleading, Numerous Professional Experts Aghast.
			
	
		
	



	
		เกี่ยวกับเรา
	
	
		
	



	
		In 1993, Biogenetech started with just 10 staff, distributing diagnostic kits and nuclear medicines.

In the past 25 years, Biogenetech introduced more than 15 innovative vaccines and pharmaceuticals, contributing to the improvements in public health standards in Thailand, protecting our population from numerous infectious diseases!

	



	
	อ่านเพิ่มเติม


        

        
                    
                
                    Related Health Education
                                        
                        
                            
                                
                                    ทำไม “อินโดนีเซีย” ไม่ฉีดวัคซีนโควิดให้ผู้สูงอายุก่อน?                                
                            
                        
                                        
                        
                            
                                
                                    COVID-19 News: America Finally Has Its Own SARS-CoV-2 Variant COH.20G/501Y with More Worst and Complex Variants to Debut Shortly!                                
                            
                        
                                        
                        
                            
                                
                                    Vaccine News: 23 Deaths From Pfizer’s COVID-19 Vaccine in Norway, Chinese Urges Halt to mRNA Vaccines, Legal Suits for Those Saying Vaccines are Safe!                                
                            
                        
                                        
                        
                            
                                
                                    Vaccine News: Pfizer’s Study on Vaccine Effectiveness Against New Variants and Claims are Misleading, Numerous Professional Experts Aghast.                                
                            
                        
                                        
                        
                            
                                
                                    Breaking! COVID-19 News: Japan Discovers New SARS-CoV-2 Variant Originating from Brazil, The B.1.1.248 Variant with 12 Spike Mutations!

Related Posts

Peru says China’s Sinopharm may resume coronavirus trial after volunteer’s illness

Related Health Education